与LI-RADS对齐的人工智能用于肝癌诊断:方法、证据与临床就绪度
本文为叙述性综述,汇总了CT、MRI及超声/超声造影中用于肝脏肿瘤表征的人工智能系统的方法学模式、诊断性能与临床转化就绪度,并按模态-任务对齐、外部验证、阅片者研究、稳健性分析、校准及不确定性报告评估证据质量,还提供了一份最小报告清单以促进方法学透明与可重复性。
要点
- 评估AI系统应关注其是否对齐LI-RADS语义、是否显式处理增强时序动态并纳入临床相关先验。
- 证据质量需通过外部验证、阅片者研究、稳健性分析、校准与不确定性报告来评估。
- 临床转化需要方案感知的稳健性、校准的置信度估计、按大小分层的性能报告及更广泛的多中心验证。
核心结论
- 与LI-RADS对齐的AI系统在反映放射科医生推理、显式处理增强时序动态并纳入临床相关先验时,显示出增强肝脏肿瘤诊断的强潜力;转化为实践需要方案感知的稳健性、校准的置信度估计、按大小分层的性能报告及更广泛的多中心验证。
研究设计与样本
- 叙述性综述,综合评估CT、MRI及超声/超声造影中用于肝脏肿瘤表征的AI系统的方法学模式、诊断性能与临床转化就绪度,并通过外部验证、阅片者研究、稳健性分析、校准及不确定性报告评估证据质量,提供了一份最小报告清单以支持方法学透明与可重复性。
关键影像表现/征象
- CT用于肝细胞癌、肝内胆管癌、转移瘤及良性模仿病变的鉴别诊断。
- MRI用于LI-RADS特征检测与类别赋值。
- MRI及超声造影用于LR-M的鉴别。
- 超声用于监测时代的筛查分诊。
临床应用与阅片要点
- 评估AI系统时应检查其是否对齐LI-RADS语义、是否显式处理增强时序动态并纳入临床相关先验。
- 报告AI性能时应包含外部验证、阅片者研究、稳健性分析、校准及不确定性报告。
- 临床转化需要方案感知的稳健性、校准的置信度估计、按大小分层的性能报告及更广泛的多中心验证。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Liver tumor diagnosis relies heavily on imaging, and the liver imaging reporting and data system (LI-RADS) provides a structured framework for evaluating hepatocellular carcinoma (HCC) and related entities in at-risk populations. Artificial intelligence (AI) has rapidly expanded across CT, MRI, and ultrasound/CEUS, yet its clinical credibility depends on adherence to modality-appropriate tasks, robust validation, and alignment with LI-RADS semantics. This narrative review synthesizes methodological patterns, diagnostic performance, and readiness for clinical translation of AI systems designed for liver tumor characterization across major imaging modalities. We examine modality-task alignment-including CT-based differential diagnosis of HCC, intrahepatic cholangiocarcinoma, metastases, and benign mimics; LI-RADS feature detection and category assignment on MRI; LR-M disambiguation on MRI and CEUS; and surveillance-era triage on ultrasound. Evidence quality is appraised through external validation, reader studies, robustness analyses, calibration, and uncertainty reporting. A minimal reporting checklist is provided to support methodological transparency and facilitate reproducibility. Across modalities, AI systems show strong potential to enhance liver tumor diagnosis when they mirror radiologist reasoning, explicitly handle temporal enhancement dynamics, and incorporate clinically relevant priors. Translation into practice will require protocol-aware robustness, calibrated confidence estimates, size-stratified performance reporting, and broader multi-center validation. When developed under these principles, LI-RADS-aligned AI may meaningfully improve consistency, interpretability, and scalability in imaging-based liver cancer care.
引用
- Abuhassan Q, Oriquat G, Ganesan S, et al. LI-RADS-aligned artificial intelligence for liver cancer diagnosis: methods, evidence, and clinical readiness. Abdom Radiol (NY). 2025. PMID: 41417075. doi:10.1007/s00261-025-05329-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。